AndreaBozzo/ceres-open-data-index huggingface dataset:
Prevalence of attention deficit/hyperactivity disorder among adults in obesity treatment

Background
          Bariatric patients showing poor "focus" during treatment more often failed to lose weight or maintain reduced weight. Evaluation of these patients identified a number having attention deficit/hyperactivity disorder (ADHD), evidently a potent factor limiting successful weight control. After searches found no published reports describing comorbid ADHD and obesity, this report was conceived to begin exploring the prevalence and characteristics of these patients.
        
        
          Method
          Clinical records of 215 patients receiving obesity treatment during 2000 were reviewed. Data collected and analyzed included age, sex, beginning and ending body mass index (BMI), number of clinic visits, months of treatment, and diagnostic category (ADHD, some ADHD symptoms, non-ADHD). DSM-IV criteria were used, except age of onset was modified to <= 12 years.
        
        
          Results
          Whole sample ADHD prevalence was 27.4% (CI:21.1,32.9), but 42.6% (CI: 36.3% to 48.9%) for BMI >= 40. Mean weight loss among obese patients with ADHD (OB+ADHD) was 2.6 BMI (kg/m2) vs. 4.0 for non-ADHD (NAD) (p < 0.002). For BMI >= 40, OB+ADHD had BMI loss 2.9 vs. 7.0 (NAD) (p < 0.004). OB+ADHD had more clinic visits, with a trend  toward longer treatment duration.
        
        
          Conclusions
          ADHD was highly prevalent among obese patients and highest in those with extreme obesity. Comorbid obesity and ADHD symptoms rendered treatment less successful compared to NAD counterparts. Reasons for the comorbidity are unknown, but may involve brain dopamine or insulin receptor activity. If replicated in further studies, these findings have important implications for treatment of severe and extreme obesity.
Compound 530271: 3-[2-(3,4-Dimethoxyphenyl)-2-oxoethyl]-5-phenyl-1,3,4-oxadiazol-2(3H)-one

Chemical compound data from PubChem database. IUPAC Name: 5-ethyl-6-pentyldodecane. Molecular Formula: C19H40. Molecular Weight: 268.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400391-T1: [Translated] ROTATING FRICTION WELDING OF METAL MATRIX COMPOSITE BODIES, IRON ALLOYS, NON-FERROUS ALLOYS AND SUPER ALLOYS USING A HIGHLY ABRASIVE TOOL

A probe for friction stir welding MMCs, ferrous alloys, non-ferrous alloys, and superalloys, as well as non-ferrous alloys, the probe including a shank, a shoulder, and a pin disposed through the shoulder and into the shank, wherein the pin and the shoulder at least include a coating comprised of a superabrasive material, the pin and shoulder being designed to reduce stress risers, disposing a collar around a portion of the shoulder and the shank to thereby prevent movement of the shoulder relative to the shank, and incorporating thermal management by providing a thermal flow barrier between the shoulder and the shank, and between the collar and the tool.
Exploring Case and Service Characteristics of Children in Long-Term Foster Care to Guide Organizational Decision Making for Implementing Practice and System Reforms

This presentation highlights three papers from the experiences of three Permanency Innovations Initiative (PII) grantees: Washoe County, Nevada, the California Partners for Permanency (CAPP) and the Kansas Intensive Permanency Project (KIPP). The presentation addresses the methods and analyses used to identify risk characteristics for long term foster care; the methods used to engage agency partners in their selection of strategies that will be tested; and to consider the benefits of university-agency partnerships for using implementation science to drive system and practice reforms.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 527119: Hex-2-enyl 2-methylbut-2-enoate

Chemical compound data from PubChem database. IUPAC Name: hex-2-enyl 2-methylbut-2-enoate. Molecular Formula: C11H18O2. Molecular Weight: 182.26. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Emergency Temporary Shelters - Limited Stay Exits - By Gender Identity

Under <a href="https://chicityclerkelms.chicago.gov/Matter/?matterId=6DEAA6D8-D0E6-EE11-904C-001DD806E058" target="_blank">SO2024-0008386</a>, passed by City Council on 4/17/2024, the Department of Family and Support Services publishes data on the City-operated and City-funded emergency new arrivals shelters. This series of datasets contains data related to the <a href="https://www.chicago.gov/city/en/sites/texas-new-arrivals/home/faqs.html" target="_blank">Limited Stay Policy</a>. This dataset shows the total number of migrants, by gender identity, who exited shelters under this policy, each week.

<b>The first "week" listed (3/11/2024 to 5/5/2024) is actually cumulative since exits under the Limited Stay Policy began. All subsequent weeks will be individual weeks.</b>
Washington-Arlington-Alexandria, DC-VA-MD-WV

This report presents combined 2005 to 2010 National Survey on Drug Use and Health (NSDUH) results for those aged 12 or older in the Washington-Arlington-Alexandria, DC-VA-MD-WV metro area. The report includes estimates of substance use disorder, major depressive episode, illicit drug use, marijuana use, cigarette use, binge alcohol use, and the nonmedical use of prescription-type pain relievers. Results are provided for the Washington-Arlington-Alexandria metro area, the District of Columbia and the U.S. overall.
Patent AT-E400852-T1: [Translated] SYSTEM, METHOD AND APPARATUS FOR PERFORMING A KEYWORD SEARCH

A keyterm search is a method of searching a database for subsets of the database that are relevant to an input query. First, a number of relational models of subsets of a database are provided. A query is then input. The query can include one or more keyterms. Next, a gleaning model of the query is created. The gleaning model of the query is then compared to each one of the relational models of subsets of the database. The identifiers of the relevant subsets are then output.
COVID-19 Coverage Assistance Fund: Claims Reimbursement to Health Care Providers and Facilities for Services to the Underinsured

The COVID-19 Coverage Assistance Fund provides reimbursements on a rolling basis directly to eligible health care entities for costs associated with administering COVID-19 vaccines to underinsured individuals, who are defined for this purpose as having a health plan that either does not include COVID-19 vaccine administration as a covered benefit or covers COVID-19 vaccine administration but with cost-sharing.

The program funding information is as follows: The Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136), appropriated $100 billion to reimburse eligible health care providers for health care related expenses or lost revenues that are attributable to coronavirus. The Paycheck Protection Program and Health Care Enhancement Act or PPPHCEA (P.L. 116-139) appropriated an additional $75 billion for relief funds, and the Coronavirus Response and Relief Supplemental Appropriations (CRRSA) Act appropriated an additional $3 billion.  HRSA established the Provider Relief Fund (PRF) to administer payments to eligible providers. A portion of the PRF funds are being used to provide reimbursement to providers for administering Food and Drug Administration (FDA) authorized COVID-19 vaccines under an Emergency Use Authorization (EUA) or FDA-licensed COVID-19 vaccines under a Biologics License Application (BLA) to underinsured individuals. To learn more about the program, visit: https://www.hrsa.gov/covid19-coverage-assistance

This dataset represents the list of health care entities who have agreed to the Terms and Conditions and received claims reimbursement for costs associated with administering COVID-19 vaccines to underinsured individuals.

For Provider Relief Fund Data - https://data.cdc.gov/Administrative/HHS-Provider-Relief-Fund/kh8y-3es6
Compound 526485: Clopyralid-methyl

Chemical compound data from PubChem database. IUPAC Name: methyl 3,6-dichloropyridine-2-carboxylate. Molecular Formula: C7H5Cl2NO2. Molecular Weight: 206.02. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Phenotyping ofCampylobacter jejuniandCampylobacter coliby a quantitative antibiogram [MIC] typing scheme using Euclidean distances [QATED]

EnteropathogenicCampylobacter jejuniandC. coliare presently the most common cause of acute bacterial gastroenteritis in the developed world. An understanding of sources and means of transmission ofCampylobacteris an essential factor in order to reduce the incidence ofCampylobacter-related gastroenteritis in man. Consequently a reproducible, sensitive and well-standardised typing scheme is critical in the successful discrimination of strains and in the subsequent investigations of outbreaks. For this purpose, a phenotypic typing scheme based on quantitative antibiogram determination based on Euclidean distance (QATED), was developed.
Compound 528379: 2,3,6-Trichloro-4-hydroxybenzaldehyde

Chemical compound data from PubChem database. IUPAC Name: 2,3,6-trichloro-4-hydroxybenzaldehyde. Molecular Formula: C7H3Cl3O2. Molecular Weight: 225.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Program Instruction (PI-07-05)

This Program Instruction (PI) provides instruction to states on the June 30, 2007 submission of the Annual Progress and Services Report (APSR) required under Title IV-B of the Social Security Act (the Act), the Child Abuse Prevention and Treatment Act (CAPTA), and the Chafee Foster Care Independence Program (CFCIP), including the ETV program; the submission of the CFS-101, Part I, Annual Budget Request, Part II, Annual Summary of Child and Family Services, and Part III, Annual Expenditure Report—Title IV-B, Subparts 1 and 2, Chafee Foster Care Independence Program (CFCIP) and Education and Training Vouchers (ETV).

Metadata-only record linking to the original dataset. Open original dataset below.
2013 NSDUH Dependence, Abuse, and Treatment Tables  (Prevalence Estimates) - 5.1 to 5.56

These detailed tables present totals and prevalence estimates of substance dependence/abuse and treatment need/receipt from the 2013 National Survey on Drug Use and Health (NSDUH). Substances examined include illicit drugs, marijuana, cocaine, heroin, hallucinogens, inhalants, and the nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, and sedatives, and alcohol. Results are provided by age group, gender, race/ethnicity, education level, employment status, and geographic area. Comparisons are made between 2013 and 2012.
Compound 525897: N,N-Dimethyl-N'-butyl-pivalamidine

Chemical compound data from PubChem database. IUPAC Name: N'-butyl-N,N,2,2-tetramethylpropanimidamide. Molecular Formula: C11H24N2. Molecular Weight: 184.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530387: Acetophenone, oxime, TMS

Chemical compound data from PubChem database. IUPAC Name: 1-phenyl-N-trimethylsilyloxyethanimine. Molecular Formula: C11H17NOSi. Molecular Weight: 207.34. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530149: 4-Methoxyphenylpropionic acid trimethylsilyl ester

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 3-(4-methoxyphenyl)propanoate. Molecular Formula: C13H20O3Si. Molecular Weight: 252.38. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Plan ID Crosswalk PUF - PY2017

The Plan ID Crosswalk PUF (CW-PUF) is one of the files that make up the Marketplace PUF. The purpose of the CW-PUF is to map QHPs and SADPs offered through the Marketplaces in 2014 to plans that will be offered through the Marketplaces in 2015. These data either originate from the Plan Crosswalk template (i.e., template field), an Excel-based form used by issuers to describe their plans in the QHP application process, or were generated by CCIIO for use in data processing (i.e., system-generated).This data dictionary describes the variables contained in the CW-PUF. Each record relates to a mapping between a plan offered in 2014 and a plan offered in 2015 at the county or county-zip code level.
Compound 530019: 3-Ethoxy-4-[(trimethylsilyl)oxy]benzaldehyde

Chemical compound data from PubChem database. IUPAC Name: 3-ethoxy-4-trimethylsilyloxybenzaldehyde. Molecular Formula: C12H18O3Si. Molecular Weight: 238.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530248: 1-Isopropyl-4-methyl-1,2-cyclohexanediol

Chemical compound data from PubChem database. IUPAC Name: 4-methyl-1-propan-2-ylcyclohexane-1,2-diol. Molecular Formula: C10H20O2. Molecular Weight: 172.26. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528712: 1-Methyl-3-(prop-1-EN-1-YL)trisulfane

Chemical compound data from PubChem database. IUPAC Name: 1-(methyltrisulfanyl)prop-1-ene. Molecular Formula: C4H8S3. Molecular Weight: 152.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527611: Allyl dibromoacetate

Chemical compound data from PubChem database. IUPAC Name: prop-2-enyl 2,2-dibromoacetate. Molecular Formula: C5H6Br2O2. Molecular Weight: 257.91. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
4.11b Facilities offering special programs or groups for specific client types, by facility operation and primary focus of facility: 2010. Percent

This is a National Survey of Substance Abuse Treatment Services (N-SSATS) data table showing facilities offering special programs or groups for specific client types, by facility operation and primary focus of facility in 2011. N-SSATS is designed to collect data on the location, characteristics, and use of alcohol and drug abuse treatment facilities and services throughout the 50 States, the District of Columbia, and other U.S. jurisdictions.
Compound 526489: Silane, (1,1-dimethylethyl)ethoxydimethyl-

Chemical compound data from PubChem database. IUPAC Name: tert-butyl-ethoxy-dimethylsilane. Molecular Formula: C8H20OSi. Molecular Weight: 160.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Hospital Cost Report Audited Data Print Image: 2020

This print image version of the Institutional Cost Report (ICR) has been audited by the DOH. is the Institutional Cost Report (ICR) is a uniform report completed by New York hospitals to report income, expenses, assets, liabilities, and statistics to the Department of Health (DOH). Under DOH regulations, (Part 86-1.2), Article 28 hospitals are required to file financial and statistical data with DOH annually. The data filed is part of the ICR and is received electronically through a secured network. This data is used to develop Medicaid rates, assist in the formulation of reimbursement methodologies, and analyze trends. For more information, check out: http://www.health.ny.gov/facilities/hospital/
Methylphenidate hydrochloride

Methylphenidate Hydrochloride (LA) is a generic extended-release capsule containing 10 mg of methylphenidate, a central nervous system stimulant prescribed to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. It is taken orally and is a controlled substance (Schedule II). Manufactured by Dr. Reddy's Laboratories Inc. under ANDA200886. This information was generated using AI and is provided for informational and research purposes only.
Compound 529339: 1H-Imidazole, 5-methyl-1-pentyl

Chemical compound data from PubChem database. IUPAC Name: 5-methyl-1-pentylimidazole. Molecular Formula: C9H16N2. Molecular Weight: 152.24. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527095: (4,6-Diacetyloxy-1,3,5-triazin-2-yl) acetate

Chemical compound data from PubChem database. IUPAC Name: (4,6-diacetyloxy-1,3,5-triazin-2-yl) acetate. Molecular Formula: C9H9N3O6. Molecular Weight: 255.18. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527560: 1,3-Cyclohexadiene, 6-iodo-1-methyl

Chemical compound data from PubChem database. IUPAC Name: 6-iodo-1-methylcyclohexa-1,3-diene. Molecular Formula: C7H9I. Molecular Weight: 220.05. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401643-T1: [Translated] SOUND-RESISTANT MULTI-COMPONENT LAYER FOR A SOUND-ABSORBING PANEL AND PANEL USING SUCH A LAYER

The panel, comprising a cellular core (1) with a sounddamping layer (2) on one side and a total reflective layer (3) on the other, has the sound-damping layer made from a structural component (4) of resinbound fibres in contact with and parallel to the aerodynamic flow, a dissipating layer (6) of metallic fabric and a second structural component (7) of resin-bound fibres lying orthogonal to the aerodynamic flow. The two structural components have open surfaces and are made from glass, carbon or polymer fibres, and the metallic fabric is preferably of stainless steel.
Patent AT-E401670-T1: [Translated] IMPROVEMENT OF FRICTION MATERIALS

The actuator has a sliding sleeve (1), and an active piston (2) that slides axially in the sleeve and includes with sections (4) made of multi-layers of piezoelectric ceramic. Each piston section has electrodes which control the sections in an independent manner. The sleeve and the piston have, at their interface, a couple of friction layers (3) made of materials with static and dynamic coefficient of friction greater than 0.6.
Table 3. Marijuana Use in the Past Month among Persons Aged 12 or Older, by State and Substate Regions: Percentages, Annual Averages Based on 2008, 2009, and 2010 NSDUHs

This table presents the 2008 to 2010 National Survey on Drug Use and Health (NSDUH) estimates of past month marijuana use by those aged 12 or older by State and substate regions.
Patent AT-E401005-T1: [Translated] USE OF FERMENTED MILK PRODUCT CONTAINING L. CASEI FOR PREPARING A COMPOSITION FOR THE PREVENTION OR TREATMENT OF DELAYED TYPE HYPERSENSITIVITY REACTIONS

The present invention relates to the field of probiotics. More particularly, the invention pertains to the use of a particular strain,  Lactobacillus casei  CNCM I-1518, which is present in Actimel®, for alleviating the symptoms of a delayed-type hypersensitivity reaction.
Bepotastine besilate ophthalmic solution 1.5% Edit metadata

Bepotastine Besilate Ophthalmic Solution 1.5% is a prescription eye drop used to relieve itching caused by allergic conjunctivitis. Manufactured by Alembic Pharmaceuticals Inc., it contains bepotastine besilate, an antihistamine that blocks histamine receptors in the eyes. Apply 1 drop to each affected eye twice daily. Available in 5 mL or 10 mL bottles. This information was generated using AI and is provided for informational and research purposes only.
Inter-rater agreement in the scoring of abstracts submitted to a primary care research conference

Background
          Checklists for peer review aim to guide referees when assessing the quality of papers, but little evidence exists on the extent to which referees agree when evaluating the same paper. The aim of this study was to investigate agreement on dimensions of a checklist between two referees when evaluating abstracts submitted for a primary care conference.
        
        
          Methods
          Anonymised abstracts were scored using a structured assessment comprising seven categories. Between one (poor) and four (excellent) marks were awarded for each category, giving a maximum possible score of 28 marks. Every abstract was assessed independently by two referees and agreement measured using intraclass correlation coefficients. Mean total scores of abstracts accepted and rejected for the meeting were compared using an unpaired t test.
        
        
          Results
          Of 52 abstracts, agreement between reviewers was greater for three components relating to study design (adjusted intraclass correlation coefficients 0.40 to 0.45) compared to four components relating to more subjective elements such as the importance of the study and likelihood of provoking discussion (0.01 to 0.25). Mean score for accepted abstracts was significantly greater than those that were rejected (17.4 versus 14.6, 95% CI for difference 1.3 to 4.1, p = 0.0003).
        
        
          Conclusions
          The findings suggest that inclusion of subjective components in a review checklist may result in greater disagreement between reviewers. However in terms of overall quality scores, abstracts accepted for the meeting were rated significantly higher than those that were rejected.
CTLA4 gene polymorphisms are associated with, and linked to, insulin-dependent diabetes mellitus in a Russian population

Background
          The association between the human cytotoxic T lymphocyte-associated antigen-4 (CTLA4) gene and insulin-dependent diabetes mellitus (IDDM) is unclear in populations. We therefore investigated whether the gene conferred susceptibility to IDDM in a Russian population. We studied two polymorphic regions of the CTLA4 gene, the codon 17 dimorphism and the (AT)n microsatellite marker in the 3' untranslated region in 56 discordant sibling pairs and in 33 identical by descent (IBD) affected sibships.
        
        
          Results
          The Ala17 allele of the CTLA4 gene was preferentially transmitted from parents to diabetic offspring (p < 0.0001) as shown by the combined transmission/disequlibrium test (TDT) and sib TDT (S-TDT) analysis. A significant difference between diabetic and non-diabetic offspring was also observed for the transmission of alleles 17, 20, and 26 of the dinucleotide microsatellite. Allele 17 was transmitted significantly more frequently to affected offspring than to other children (p = 0.0112) whereas alleles 20 and 26 were transmitted preferentially to non-diabetic sibs (p = 0.045 and 0.00068 respectively). A nonrandom excess of the Ala17 CTLA4 molecular variant (maximum logarithm of odds score (MLS) of 3.26) and allele 17 of the dinucleotide marker (MLS = 3.14) was observed in IBD-affected sibling pairs.
        
        
          Conclusion
          The CTLA4 gene is strongly associated with, and linked to IDDM in a Russian population.